FDA Inspection 1324546 — South Florida Institute For Reproductive Medicine
The FDA completed an inspection of South Florida Institute For Reproductive Medicine on Jun 30, 2026 in Jupiter, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 30, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jupiter, FL (United States)